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Abstract
Introduction Esophageal cancer is an aggressive disease with a strong tendency to infiltrate into surrounding structures. The aim
of the present study is to determine the additional value of bronchoscopy for detecting invasion of the tracheobronchial tree after
endoscopic ultrasonography (EUS) in the preoperative assessment of patients with esophageal cancer at or above the carina.
Materials and Methods Between January 1997 and December 2006, 104 patients were analyzed for histologically proven
esophageal cancer at or above the carina. All patients underwent both EUS and bronchoscopy (with biopsy on indication) in
the preoperative assessment of local resectability.
Results and Discussion After extensive diagnostic workup, 58 of 104 patients (56%) were eligible for potentially curative
esophagectomy; nine of these 58 patients (9/58, 15%) appeared to be incurable peroperatively because of ingrowth in the
tracheobronchial tree (five patients), ingrowth in other vital structures (two patients) or distant metastases (two patients). Of the 46
non-operable patients, local irresectability (T-stage 4) was identified in 26 patients (26/46, 57%) due to invasion of vital structures
on EUS: invasion of the aorta in six patients, invasion of the lung in 11 patients; in 12 patients invasion of the tracheobronchial tree
was described, which was confirmed by bronchoscopy in only five patients. No patients with T4 were identified by bronchoscopy
alone.
Conclusion For patients with esophageal tumors at or above the carina, no additional value of bronchoscopy (with biopsy on
indication) to exclude invasion of the tracheobronchial tree was seen after EUS in a specialized centre. Although based on
relatively small numbers, we conclude that bronchoscopy is not indicated if no invasion of the airways is identified on EUS.
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Introduction
Esophageal cancer is an aggressive disease with early
lymphatic and hematogeneous dissemination, and a strong
tendency to infiltrate into surrounding structures. Despite
many improvements in diagnostic and therapeutic strate-
gies, the prognosis is still unfavorable.1–4
The proximal part of the intrathoracic esophagus is
located between the trachea and the vertebral column.
Therefore, esophageal tumors at or above the carina tend to
invade the tracheobronchial tree, precluding curative surgery.
To assess local resectability endoscopic ultrasonography
(EUS) is generally considered the most accurate modality
as it is able to visualize distinct esophageal wall layers with
an accuracy of more than 90%.5 Because of the great
therapeutic consequences of tracheobronchial ingrowth, the
preoperative workup of the patients with these proximal
tumors frequently also includes bronchoscopy (with biopsy
on indication) to exclude airway invasion.6,7 The usefulness
of bronchoscopy in patients with proximal tumors has been
investigated extensively, although not in relation to the
accuracy of EUS to determine involvement of the airways.8,9
Therefore, the aim of the present study was to determine
the additional value of preoperative bronchoscopy (with
biopsy on indication) for detecting invasion of the
tracheobronchial tree after having performed EUS in a
specialized centre.
Patients and Methods
Patients
Patients visiting the outpatient clinic of our hospital for
newly diagnosed esophageal cancer between January 1997
and December 2006 were included in this analysis. Eligible
patients had histologically proven cancer of the upper and/
or middle thoracic esophagus. Patients were excluded if
EUS or bronchoscopy was not performed and in case of
subcarinal localization of the esophageal tumor.
Endoscopic Ultrasonography
A radial scanner (GF-UM130 or GF-UM160, 5–20 MHz,
Olympus Medical Systems, Tokyo, Japan) was used for
EUS. In case of a stenotic tumor that did not allow passage
of the standard echo-endoscope, a small-caliber probe (Mh-
908, 7.5 MHz, Olympus Medical Systems, Tokyo, Japan)
was used in an attempt to traverse the tumor. EUS was
performed with the patient in a left decubitus position under
conscious sedation using 2.5–10 mg midazolam intrave-
nously. All investigations were performed by or supervised
by a gastroenterologist experienced in EUS.
A lesion was considered to invade the trachea on EUS if
endosonographically the hyper-echoic interphase of the
esophagus and trachea was interrupted. Close approxima-
tion of the tumor without such interruption was still
considered compatible with T3 stage.
Bronchoscopy
Bronchoscopy was performed using a flexible videobroncho-
scope (BF-P160, Olympus Optical, Tokyo, Japan) via a
transnasal approach after premedication with 2% lidocaine
spray in nose and throat (up to 50 ml). During the examination
2% lidocaine spray was administered into the trachea and
bronchi via the bronschoscope. No systemic medication was
used. All investigations were performed by an experienced
pulmonary physician. The complete tracheobronchial tree was
inspected; laryngeal structures were included in the examina-
tion. All direct tumor signs (especially intraluminal growth
and mucosal break) and indirect tumor signs (especially
mobility of pars membranacea during coughing, bulging/
compression) were recorded. Mucosal brushing or biopsies
were performed only if mucosal abnormalities were suspected.
No bronchoalveolar lavage was performed; however,
rinsing fluid from brushing or biopsies was sent for
cytologic examination.
Other Investigations
Computed tomography (CT) of the chest and abdomen and
external ultrasonography of the neck were also performed
in all patients to exclude distant metastases.
Endoscopic ultrasonography, CT, and external ultraso-
nography of the neck were performed in a random order;
however, bronchoscopy was always performed after EUS.
The bronschoscopist was aware of the other clinical data. If
EUS showed a T3 tumor, while a T4 tumor was suspected
on CT, EUS was used to determine the final T stage. All
investigations were performed before any form of therapy
was started.
Neoadjuvant Therapy
Due to the time span of this study, different neoadjuvant
regimens were applied. In the first period, patients with
squamous cell carcinoma received neoadjuvant chemother-
apy consisting of two or four cycles of cisplatin and
etoposide (depending on the tumor regression on CT after
two cycles). In later years, patients received neoadjuvant
chemoradiotherapy (five cycles of paclitaxel and carbopla-
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tin with concurrent radiation of 41.4 Gy) as part of a
randomized clinical trial comparing surgery alone versus
neoadjuvant chemoradiotherapy and surgery for squamous
cell carcinoma and adenocarcinoma.
Surgical Resection
Because of the high localization of the tumor, in all patients
who were considered eligible for potentially curative
surgery, an esophagectomy was performed via the extended
transthoracic approach with two field lymphadenectomy. A
gastric tube was constructed and esophagogastrostomy was
performed in the neck without cervical lymphadenectomy.
Tumor extent and airway invasion were assessed intra-
operatively. If distant metastases and/or local irresectability
due to invasion of vital structures was encountered,
resection was abandoned.
Statistical Analysis
Tracheobronchial invasion on EUS, bronchoscopy (with
positive biopsy results) and/or during operation was
considered the gold standard for the presence of tracheo-
bronchial invasion. No tracheobronchial invasion on EUS
and/or bronchoscopy was considered as false negative if
local irresectability was encountered during operation.
Results
Clinicopathological Characteristics
Between January 1997 and December 2006, a total of 106
patients presented at our outpatient clinic for analysis of a
newly diagnosed histologically proven, esophageal malig-
nancy at or above the carina. Two patients were excluded as
EUS was not performed. The clinicopathological character-
istics of all 104 patients are summarized in Table 1. The
majority of patients were male (64 patients, 62%) and the
mean age was 61 years (range 32–85 years). Histology
showed squamous cell carcinoma in 93 patients (89%) and
adenocarcinoma in 11 patients (11%). Tumors were
mainly localized in the middle thoracic part of the
esophagus (75 patients, 72%). A total of 98 patients
(94%) were referred from another hospital. In total, 24
patients (23%) received neoadjuvant chemotherapy and
six patients (6%) received neoadjuvant chemoradiotherapy
(of whom one patient was with adenocarcinoma). A
complete surgical resection was performed in 49 patients
(47%), whereas in nine patients (9%) resection was
abandoned as local irresectability or distant metastases
were encountered peroperatively. In 46 patients (44%), the
treatment was primarily palliative.
Staging and Treatment
Endoscopic ultrasonography described T-stages 1 to 3 in 78
patients (78/104, 75%; Table 2, Fig. 1). EUS described
local irresectability due to: invasion of the tracheobronchial
tree in 12 patients (12/104, 12%), invasion of the aorta in
six patients (6/104, 6%), invasion of the lung in 11 patients
(11/104, 11%). In four patients invasion of multiple
structures was seen: in two patients invasion of the aorta
and the lung; in one patient invasion of the tracheobron-
chial tree and the lung; in one patient invasion of the
tracheobronchial tree, the aorta, and the lung.
Bronchoscopy showed a fixed pars membranacea in five
patients (5/104, 5%), bulging in 36 patients (36/104, 35%),
and true invasion of the tracheobronchial mucosa (with
positive biopsies) in only five of the patients (5/104, 5%).
In five patients, more than one indirect and/or direct sign
was seen; in three patients bulging and invasion, in one
patient a fixed pars membranacea and bulging, and in one
patient a fixed pars membranacea and bulging and invasion
was seen.
Distant metastases were found in 12 patients (12/104,
12%). Eight patients were not suitable for surgery due to a
poor general health condition (8/104, 8%).
Table 1 Clinicopathological Characteristics of 104 Patients Visiting
the Outpatient Clinic for Newly Diagnosed Histologically Proven
Esophageal Cancer at or Above the Carina between January 1997 and
December 2006
Number of patients (n=104)
Gender
M/F 64/40 (62%/38%)
Age
Mean (range) [years] 61 (32–85)
Histology
Squamous cell carcinoma 93 (89%)
Adenocarcinoma 11 (11%)
Tumor localization
Cervical esophagus 7 (7%)
Upper thoracic esophagus 22 (21%)
Middle thoracic esophagus 75 (72%)
Referral
From other hospital 98 (94%)
Therapy
Preoperative chemotherapya 24 (23%)
Preoperative chemoradiationb 6 (6%)
Surgical resection 49 (47%)
Surgical exploration 9 (9%)
Primarily palliative treatment 46 (44%)
M male, F female
a Two–four cycles of Cisplatin and Etoposide
b Five cycles of paclitaxel and carboplatin with concurrent 41.4-Gy
radiation
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After completion of the staging procedures, 58 patients
were found suitable for potentially curative surgery (56%).
In nine patients (9/58, 15%) resection was abandoned
peroperatively because of: invasion of the tracheobronchial
tree (five patients, 5/58, 8%), invasion of other vital
structures (two patients, 2/58, 3%) and distant metastases
(two patients, 2/58, 3%). Time between analysis and
surgery did not differ between patients undergoing resec-
tion and in patients found to be irresectable peroperatively
(median 2.9 months and 2.6 months, respectively).
Additional Value of Bronchoscopy
Indirect signs were seen on bronchoscopy in 40 patients
(40/104, 38%). Invasion of the tracheobronchial tree was
diagnosed or encountered during operation in 17 patients
(17/104, 16%) (Table 3). Indirect signs were seen during
bronchoscopy in 29% of the patients (25/87) without
invasion of the tracheobronchial tree (false positives), and
no indirect signs were seen in 12% of the patients (2/17)
with invasion of the tracheobronchial tree (false negatives).
This results in a sensitivity of 88% and a specificity of 71%
of indirect signs seen on bronchoscopy reflecting invasion
of the tracheobronchial tree.
Discussion
Preoperative staging in patients with esophageal cancer is
an extensive diagnostic process. To detect incurable
patients before surgery, various modalities are being used.
Invasion of the airways is common in tumors located at or
above the carina. Invasion of the tracheobronchial tree can
be assessed by different diagnostic modalities, especially
CT, magnetic resonance imaging (MRI), EUS, and bron-
choscopy. In the literature, CT and MRI both show low
accuracy compared to EUS to determine T stage (45% and
60%, respectively).10,11 Therefore, it was investigated in the
present study whether performing bronchoscopy after EUS
has any additional value. In this study, bronchoscopy did
not detect any patients with airway invasion that was not
already detected by EUS. Remarkably, five patients (5/58,
8%) were found to have airway invasion during surgery,
which had been missed by both EUS and bronchoscopy.
Bronchoscopy is capable of directly detecting airway
invasion if the tumor has breached the epithelium. If a
wider definition of invasion would be used and indirect
signs (esp. bulging and a fixed pars membranacea) would
also be taken into account, the value of bronchoscopy
might possibly rise. Baisi et al. evaluated invasion of the
tracheobronchial tree in 91 patients with esophageal cancer
by bronchoscopy.12 They concluded that compression of
the tracheobronchial tree (bulging) does not necessarily
indicate infiltration by the esophageal tumor; however, if
also a fixed pars membranacea is seen, there is a frank
infiltration, making radical resection highly unlikely. Riedel
et al. have investigated 116 patients with bronchoscopy.13
Remarkably, they found microscopic proof of invasion in
only 4% of patients showing indirect signs on bronchosco-
py, whereas the remaining 96% of the patients underwent a
radical resection. If in the present study, indirect signs were
used as well, an unnecessary surgical exploration would
have been prevented in two patients (12%). However, 25
patients (29%) would have been wrongly diagnosed with
irresectable cancer.
Endoscopic ultrasonography via the esophagus examines
the airways from an opposite angle, making it possible to
detect airway invasion without a mucosal break, i.e. in an
earlier stage. This fundamental difference could explain
Table 2 Staging and Treatment of 104 Patients Visiting the
Outpatient Clinic for Newly Diagnosed Histologically Proven Esoph-
ageal Cancer at or Above the Carina between January 1997 and
December 2006
Number of patients (n=104)
EUS
T1–3 78 (75%)
T4 26 (25%)
Invasion tracheobronchial treea 12 (12%)
Invasion aortaa 6 (6%)
Invasion lunga 11 (11%)
Otherb 2 (2%)
Bronchoscopyc
Fixed pars membranacea 5 (5%)
Bulging 36 (35%)
Invasion tracheobronchial treed 5 (5%)
Other contraindications for surgery
Distant metastases 12 (12%)
Poor general health 8 (8%)
Treatment
Potentially curative 58 (56%)
Primarily palliative 46 (44%)
Peroperative findings (n = 58)
Surgical resection 49 (84%)
Surgical exploration/no resection 9 (15%)
Invasion tracheobronchial tree 5 (8%)
Invasion other vital structures 2 (3%)
Distant metastases 2 (3%)
EUS endoscopic ultrasonography
a In four patients invasion of multiple structures was seen; in two
patients invasion of aorta and lung, in one patient invasion of
tracheobronchial tree and lung and in one patient invasion of all three
sites was seen
b Other: invasion of right carotic artery in one patient, invasion of
pericardium in one patient
c In five patients more than one indirect and/or direct sign was seen; in
three patients bulging and invasion, in one patient fixed pars
membranacea and bulging, and in one patient all three signs were seen
d Cyto- and/or histologically proven
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why EUS detects more patients with airway invasion
compared with bronchoscopy. It should be realized, that
EUS uses indirect signs as well in order to describe the
T-stage and thus it is very much operator- and experience-
dependent. Fockens et al. have described the prognosis of
patients diagnosed with irresectable (T4) tumors on EUS,
and found that these patients have a very poor prognosis,
regardless of further therapy (including potentially curative
surgery).14 In their analysis, 24 of 51 patients (47%)
underwent explorative surgery (despite EUS T-stage 4);
however, only 13 underwent a surgical resection, and in
only three of these patients the resection was microscopi-
cally radical.
In the present study, bronchoscopic ultrasonography was
not addressed. To our knowledge, only one study has
compared esophageal ultrasonography, conventional bron-
choscopy, and bronchoscopic ultrasonography for detecting
airway invasion.15 Unfortunately, only 44% of the patients
underwent esophageal ultrasonography due to stenosis.
This study found accuracy rates for invasion of the airways
of 91% with bronchoscopic ultrasonography, 78% with
conventional bronchoscopy, and 85% with esophageal
ultrasonography. The authors conclude that bronchoscopic
ultrasonography is a safe and promising technique to
determine local resectability. However, it should be taken
into account that (bronchoscopic) ultrasonography is an
invasive modality and the burden for the patient is
relatively high.16–18
There are some limitations to the present study. The total
number of patients is relatively small. Moreover, the
percentage of patients in whom airway invasion was not
detected until surgical exploration is relatively high. Time
between analysis and surgery was not significantly longer
compared with the patients who underwent resection.
In conclusion, bronchoscopy has no additional value in this
study as a standard diagnostic modality for staging of patients
with esophageal cancer at or above the carina after EUS in a
specialized centre. Although based on small numbers, we
Table 3 Presence of Indirect Signs on Bronchoscopy of All 104
Patients
Number of patients (n=104)
Invasion tracheobronchial tree
Present Absent
Indirect signs on bronchoscopy
Present 15 25
Absent 2 62
Total 17 87
“Indirect signs” implies a fixed pars membranacea, bulging and/or
invasion of the tracheobronchial tree (cyto-/histologically proven).
“Invasion tracheobronchial tree” implies tracheobronchial invasion on
EUS, bronchoscopy (with positive biopsy results) and/or encountered
during operation
104 pts
potentially curative
resection?
58 pts YES46 pts NO
peroperative
9 pts no resection
49 pts
resection
5 pts invasion tracheobronchial tree
2 pts invasion other vital structures
2 pts distant metastases
8 pts poor general health
12 pts T1-3 with distant
metastases
12 pts invasion tracheobronchial tree*
6 pts invasion aorta*
11 pts invasion lung*
2 pts other**
Figure 1 Flowchart of 104
patients visiting the outpatient
clinic for newly diagnosed his-
tologically proven esophageal
cancer at or above the carina
between January 1997 and De-
cember 2006. pts patients, NO
not potentially curable, YES po-
tentially curable. Asterisk: In
four patients invasion of multi-
ple structures was seen; in two
patients invasion of the aorta
and the lung, in one patient
invasion of the tracheobronchial
tree and the lung, and in one
patient invasion of the tracheo-
bronchial tree, the aorta, and the
lung was seen. Two asterisks,
other: invasion of the right
carotid artery in one patient,
invasion of the pericardium and
multiple metastatic lymph nodes
in the neck, mediastinum, and
abdomen in one patient.
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conclude that bronchoscopy is not indicated if no invasion of
the airways is identified on EUS. However, bronchoscopy (if
possible in combination with bronchoscopic ultrasonography)
should be performed if because of esophageal stenosis EUS is
not feasible. If irresectability is identified during operation,
bronchoscopy should rule out direct tumor invasion of the
mucosa before radiotherapy is started, to prevent the
development of a tracheo-esophageal fistula.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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